RNAi
| 6 min read
With the first wave of FDA-approved siRNA drugs under their belt, companies are racing to expand into new tissues and indications.
Available on Demand
Explore innovative methods to enhance RNA purification efficiency and ensure scalable, high-quality RNA production.
| 2 min read
Qfitlia, an RNAi therapeutic given every two months, is the first to target the antithrombin protein instead of missing clotting factors in the blood.
| 8 min read
Alnylam Pharmaceuticals develops therapeutics based on the RNA interference (RNAi) pathway discovered in 1998.
| 3 min read
As an alternative to daily pills, a new RNAi drug could lower blood pressure with a twice-yearly injection.
Page 1 of 1 - 5 Total Items
